Rumi Young

Director, Regulatory Policy
Novo Nordisk

Rumi Young serves as Director of Regulatory Policy at Novo Nordisk, leading innovation and market acceleration for medical devices and combination products. Previously, she was Acting Assistant Director for Injection Devices at FDA’s CDRH, following eight years at Genentech and AstraZeneca. She holds Chemistry and Material Science Engineering degrees from Cornell University.

Disclosure information not submitted.

Presentation(s):

• EDDO Combination Product Control Strategies and Best Practices

  Thursday, November 13, 2025
  2:30 PM - 3:30 PM East Coast USA Time

• Navigating Human Factors for Combination Products, Including Generic: URRA, Threshold Analysis and Post Market

  Friday, November 14, 2025
  8:10 AM - 9:25 AM East Coast USA Time